spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

2nd Annual Clinical Trial Supply East Asia

6-7 December 2017
Seoul, South Korea

This is the only event focusing Clinical Trials Supply in Korea. This event focuses on providing discussions to achieve efficient and seamless clinical supply for trials, as well as providing an In-depth overview into the key regulatory challenges faced by companies in the East Asia region. This is a unique event encompassing discussions around strategies to ensure smooth clinical trial supply chain

In addition to this, the event will look at a the newest innovations in clinical trial supply at an event that will bring together key professionals across different companies and combine the knowledge of both small, emerging the perfect opportunity for attendees to discuss with competitors, service providers and companies of different sizes the best ways to implement their strategy

Why This Event – Why Now?

The landscape of clinical trials in Asia is changing. Many of the global pharmaceutical companies may have first decided to move to Asia for the patient pool and cheaper cost. However, the whole spotlight in Asia is now impacting the pharmaceutical sector rather than just the mere clinical trials industry. Companies need to set their strategic sights on a future world where Asia is not just a market for the pharma industry, but could make a key contribution to drug discoveries as well.
 
Why CTS East Asia?

Asia now has more clinical trials than any other region in the world. Through research with suppliers there is some disagreement over whether the local market is growing in terms of companies, however no dispute at all in the number of trials happening in the region.

Why South Korea?

Despite much clinical activity, and certain evidence of growth in pharmaceutical industry in Asia, there are no clear signs of a compelling industry ‘cluster’ as seen in USA and Europe. Although, most countries in the region are making progress, and often with the support of the Government, few have reached the level of maturity necessary to be seen as a cluster.

For more information click here http://www.arena-international.com/ctseastasia/
 
Print this page
Send to a friend
   
spacer
Industry Events

SMi’s 9th Annual Biosimilars & Biobetters Conference

25-27 September 2018, Copthorne Tara Hotel, London, UK

Following the success of our previous events in both London and the US, Biosimilars and Biobetters UK 2018, SMi deliver a stellar speaker line-up and bring together a global audience of biosimilar experts to discuss the latest developments and future of the rapidly evolving and expanding biosimilars market.
More info >>

Banner of PHPL West Coast_events_95 on Samedan Banner of Nordics_Events_97 on Samedan

White Papers

PhlexEarchive: The Right Solution for Electronic Archiving of TMF Content

Phlexglobal Ltd

Many sponsor organizations have already recognized the value of moving from paper to electronic Trial Master Files (eTMFs). But few sponsors have taken a more holistic approach to the TMF lifecycle and looked at the entire process from study start-up through archiving of the TMF in electronic format, also known as e-archiving. The recurring value of managing, tracking, maintaining and accessing electronic files should not stop at the point of archiving. All of the challenges of managing an active paper TMF carry through to a paper archive. All of the benefits of an electronic TMF also carry through to the electronic archive. As companies look to move their compliance assets to secure, long-term storage, it is important to consider ongoing compliance requirements, security, accessibility, efficiency and costs of archiving TMF content in a digital format.
More info >>


News and Press Releases

Get on Board with a Neat Idea

Teknomek has launched a new range of anti-microbial shadow boards developed to meet the specific needs of the pharma sector. The products are made from PVC infused with Biomaster anti-bacterial silver-ion technology, which inhibits the growth of bacteria by up to 99.9%.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement